metabolic · Mechanism Report
Can MTHFR, MTR, and MTRR variants alter folate-dependent homocysteine metabolism?
These variants can influence folate-dependent homocysteine metabolism, but an individual variant’s contribution cannot be determined without genotype data.
This is what AI claimed
Variants in genes such as MTHFR, MTR, and MTRR can alter folate-dependent homocysteine metabolism, but their contribution cannot be determined without genotype data.
Executive summary
The claim says variants in MTHFR, MTR, and MTRR can shift homocysteine remethylation in a folate- and vitamin B12-dependent pathway. The graph frames this as a real but qualified effect, with folate status and biochemical findings helping shape interpretation. It also indicates that genotype-based testing is needed to assign a specific variant contribution.
Verified conclusion
Variants in MTHFR, MTR, and MTRR participate in the folate- and vitamin B12-dependent remethylation of homocysteine to methionine. The claim is supported: these variants can influence this pathway, but assigning an individual’s biochemical findings to a specific genetic variant requires genotype-based testing interpreted with laboratory and clinical data.
Clinical and biochemical evidence
- The strongest evidence is for MTHFR C677T. In a meta-analysis of intervention studies, 677TT carriers had baseline homocysteine about 2.7 μmol/L higher and serum folate about 2.5 nmol/L lower than CT/CC carriers.
- Effects of common MTR A2756G and MTRR A66G variants are less reproducible. A large family study found no association with fasting homocysteine, although some smaller studies reported genotype-associated elevations. Less-common MTR variants have functional evidence linking reduced expression with higher homocysteine and lower methionine.
Mechanistic and nutritional context
- MTHFR produces 5-methyl-THF; MTR uses 5-methyl-THF and vitamin B12 to remethylate homocysteine; MTRR reactivates MTR after oxidative inactivation.
- Folate status modifies genetic effects. Following at least four weeks of increased folate intake or folic-acid supplementation, the homocysteine difference between MTHFR genotype groups was no longer significant, though TT carriers showed a smaller serum-folate rise.
Clinical interpretation
- Plasma total homocysteine, methionine, methylmalonic acid, vitamin B12, and folate establish the metabolic phenotype and help identify acquired contributors, including renal impairment, vitamin deficiency, hypothyroidism, alcohol exposure, and medications.
- Molecular testing is necessary to attribute findings to a particular variant; for rare MTR/MTRR remethylation disorders, biallelic pathogenic variants are required. Common-MTHFR testing is not generally useful for thrombophilia, pregnancy loss, or cardiovascular-risk assessment.
Bottom line
- Genetic variants can modify homocysteine metabolism—most clearly MTHFR C677T—but genotype data are required to assign an individual genetic contribution, and biochemical/nutritional assessment remains essential for interpretation.
References
- The impact of MTHFR 677 C/T genotypes on folate status ... — pubmed.ncbi.nlm.nih.gov
- Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population - Scientific Reports — nature.com
- Disorders of Intracellular Cobalamin Metabolism - GeneReviews — ncbi.nlm.nih.gov
- First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders — onlinelibrary.wiley.com
- Methylenetetrahydrofolate Reductase Deficiency - NCBI - NIH — ncbi.nlm.nih.gov
- Guidelines for diagnosis and management of the cobalamin ... — onlinelibrary.wiley.com
See a full patient report verified like this
Book a walkthrough